You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase 3 Clinical Trial

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myopia Trial in Wenzhou (QLM3004 Concentration 1, QLM3004 Concentration 2, QLM3004 Concentration 3)

Recruiting
  • Myopia
  • QLM3004 Concentration 1
  • +3 more
  • Wenzhou, Zhejiang, China
    The Affiliated Eye Hospital of Wenzhou Medical University
Nov 21, 2023

AGA Trial in Beijing (CU-40102 Spray)

Active, not recruiting
  • AGA
  • CU-40102 Spray
  • Beijing, Beijing, China
    Peking University People Hosptial
Aug 8, 2022

Functional Dyspepsia Trial in Iksan (DA-5212, DA-5212-R)

Not yet recruiting
  • Functional Dyspepsia
  • Iksan, Muwangro 895, Korea, Republic of
    Wonkwang University Hospital
Apr 24, 2023

Noise-induced Hearing Loss Trial in Fort Jackson (D-methionine, Placebo)

Terminated
Has Results
  • Noise-induced Hearing Loss
  • Fort Jackson, South Carolina
    Moncrief Army Community Hospital
Jun 2, 2022

Pneumococcal Disease Trial in Chengdu (23-valent pneumococcal polysaccharide vaccine, control pneumococcal polysaccharide

Recruiting
  • Pneumococcal Disease
  • 23-valent pneumococcal polysaccharide vaccine
  • control pneumococcal polysaccharide vaccine
  • Chengdu, Sichuan, China
    Sichuan Center For Disease Control and Prevention
Sep 19, 2023

Dry Eye Trial in Raynham (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Completed
  • Dry Eye
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Raynham, Massachusetts
    Andover Eye Associates (Raynham)
Aug 2, 2022

Colonoscopy Trial (DWJ1609, DWC202304)

Not yet recruiting
  • Colonoscopy
  • (no location specified)
Sep 24, 2023

Rabies Trial in China (5-dose group of test vaccine, 5-dose group of control vaccine, 4-dose A group of test vaccine)

Not yet recruiting
  • Rabies
  • 5-dose group of test vaccine
  • +3 more
  • Chengdu, Sichuan, China
  • +3 more
Jul 23, 2023

Chronic Kidney Failure in Children and Young Adults Trial (Dapagliflozin, Placebo)

Not yet recruiting
  • Chronic Kidney Failure in Children and Young Adults
  • (no location specified)
Jul 10, 2023

HIV Infection Trial (DOR/ISL)

Not yet recruiting
  • HIV Infection
  • (no location specified)
Mar 1, 2023

Hypercholesterolemia, Dyslipidemia Trial in Seoul (Ezetimibe/Atorvastatin 10/5 mg, Atorvastatin 5mg, Ezetimibe 10mg)

Completed
  • Hypercholesterolemia, Dyslipidemia
  • Ezetimibe/Atorvastatin 10/5 mg
  • +7 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jul 24, 2023

Small Cell Lung Cancer Trial in Beijing (Chiauranib, Placebo)

Recruiting
  • Small Cell Lung Cancer
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
May 4, 2022

SARS-CoV-2 Trial (LVRNA009, 0.9%NaCl)

Not yet recruiting
  • SARS-CoV-2
  • LVRNA009
  • 0.9%NaCl
  • (no location specified)
Jan 11, 2023

Cardiovascular Diseases Trial (NVP-2203, NVP-2203-R1, NVP-2203-R2)

Not yet recruiting
  • Cardiovascular Diseases
  • (no location specified)
May 3, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (Camrelizumab, Gemcitabine, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 3, 2023

Diabetic Kidney Disease Trial in Sendai (Bardoxolone methyl, Placebo)

Active, not recruiting
  • Diabetic Kidney Disease
  • Bardoxolone methyl
  • Placebo
  • Sendai, Miyagi, Japan
    Japan Community Health care Organization Sendai Hospital
Jun 26, 2022

Alzheimer Trial in East Providence, Austin (Simufilam)

Enrolling by invitation
  • Alzheimer Disease
  • East Providence, Rhode Island
  • +1 more
Jan 5, 2023

SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)

Recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
  • 0.9% sodium chloride solution
  • Islamabad, Pakistan
    Sindh Infectious Diseases Hospital & Research Center Dow Univers
Apr 16, 2023

Reflux Esophagitis Trial in Guangzhou (DWP14012)

Completed
  • Reflux Esophagitis
  • Guangzhou, Guangdong, China
    Minhu Chen
Apr 2, 2023

Chikungunya Virus Infection Trial (VLA1553)

Not yet recruiting
  • Chikungunya Virus Infection
  • VLA1553
  • (no location specified)
Aug 31, 2023

Locally Advanced Gastric Cancer Trial in Fuzhou (Camrelizumab, Albumin Taxol, FLOT scheme)

Not yet recruiting
  • Locally Advanced Gastric Cancer
  • Fuzhou, Fujian, China
  • +1 more
Nov 8, 2022

Meningioma Trial in Vandœuvre-lès-Nancy (Everolimus)

Not yet recruiting
  • Meningioma
  • Vandœuvre-lès-Nancy, Grand Est, France
  • +1 more
Nov 8, 2023

NSCLC Trial (Idylla EGFR_IUO/3.20 Mutation Test)

Not yet recruiting
  • NSCLC
  • Idylla EGFR_IUO/3.20 Mutation Test
  • (no location specified)
Jul 24, 2023

H.Pylori Infection Trial in Beijing (Rifasutenizol capsules, Rabeprazole sodium enteric-coated tablets, Amoxicillin Capsules)

Not yet recruiting
  • H.Pylori Infection
  • Rifasutenizol capsules
  • +7 more
  • Beijing, China
    Peking University Third Hospital
May 3, 2023

Glioblastoma Multiforme, Adult Trial (Adaptive, two-phase RT)

Not yet recruiting
  • Glioblastoma Multiforme, Adult
  • Adaptive, two-phase RT
  • (no location specified)
Feb 8, 2023